Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Extension Study of Udenafil in Adolescents With Single Ventricle Physiology After Fontan Palliation

NCT03013751 is registered in ClinicalTrials.gov with Mezzion Pharma Co. Ltd as lead sponsor.

NCT NCT03013751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03013751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Extension Study of Udenafil in Adolescents With Single Ventricle Physiology After Fontan Palliation
Lead sponsor
Mezzion Pharma Co. Ltd
Phase
Phase 3
Overall status
Completed
Start date
February 6, 2017
Completion date
December 20, 2022
Enrollment
301 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

functional single ventricle heart disease